Tiotepa Seacross

Medicinal product

(Invented) name

Tiotepa Seacross

Active substance (s)

Tiotepa

Strength

15 mg

Pharmaceutical form

milteliai infuzinio tirpalo koncentratui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01AC01, Thiotepa

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2026-01-29

Date of renewal

Documents

3172_3173_Tiotepa Seacross_ PZ.docx

3172_3173_Tiotepa Seacross_PL.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Flakone yra:	1 vnt.
Tiotepa	15 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
120012	106115	1106115	flakonas	N1	ASPĮ	Receptinis	LT/L/26/3172/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2026-01-29	Registruotas